Recordings
Thank you for joining us for the Founder-Led Biotech Summit, where we spotlighted and supported founder-led biotech companies. Below are the recorded sessions from the events.
Welcome + Keynote Address
Tony Kulesa, co-founder of Petri, kicks off the summit with a welcome address and is joined by Reshma Shetty, co-founder of Ginkgo Bioworks, to share her story from starting the company to taking it public through a SPAC in 2021.
Co-founder,
Petri
Co-founder,
Ginkgo Bioworks
Fireside chat:
Bernat Olle
Bernat Olle is Chief Executive Officer at Vedanta Biosciences. Vedanta is pioneering rational design of drugs made of defined consortia of bacteria that are essential dwellers of the gut ecosystem.
Co-founder & CEO,
Vedanta Biosciences
Fireside chat:
Jen Nwankwo
Jen Nwankwo is the Founder and CEO at 1910 Genetics. 1910 Genetics is integrating AI computation and biological automation to accelerate the design of small molecule and protein therapeutics.
Founder & CEO,
1910 Genetics
Scientific Communication for founders
Liz Neeley, Founder and Principal of Liminal Creations, shares how to create a science story that motivates your team and captivates funders to your startup.
Founder and Principal,
Liminal Creations
getting your first term sheet
Jamie Goldstein, Founding Partner at Pillar VC, shares strategies for founders to build relationships with investors and secure capital to launch their startup.
Founding Partner,
Pillar VC
Tactics for building in Biotech
Interested in building in biotech? Tony Kulesa, co-founder of Petri, gives a talk designed to help first-time founders understand how to go from idea to action.
Co-founder,
Petri
Fireside chat:
Alice zhang
Alice Zhang is the CEO and co-founder of Verge Genomics. Verge is using human genomics to develop transformational genetic medicines.
Co-founder and CEO,
Verge Genomics
The impact of machine learning on therapeutics
Panel discussion on how machine learning enables new inference and design in biology and developing new therapeutics with the founders of Nabla Bio, New Equilibrium Biosciences and Manifold Bio.
Co-founder & CEO
Nabla Bio
Co-founder & CEO
New Equilibrium Biosciences
Co-founder & CEO
Manifold Bio
Pitch competition awards
- Alexi Choueiri
- FORAY Biosciences (Ashley Beckwith and Claudia Pienica)
- Huminly (Nikita Khlystov)
- Drūl (Brent Ifemembi and Nelson Ndahiro)
- Chelsea Goddard
Fireside chat:
sean mcclain
Sean McClain is the Founder and CEO of Absci a drug and target discovery company harnessing deep learning and synthetic biology to expand the therapeutic potential of proteins.
Founder & CEO,
Absci
The future of cell and gene therapies
Panel discussion exploring the expanding the reach of gene and cell therapy technology with the founders of Cellino and Strand Therapeutics
Co-founder & CEO,
Cellino
Co-founder & CEO,
Strand Therapeutics
Synthetic Biology and Sustainability
Panel discussion on the intersection of synthetic biology and sustainability with the founders of Compound Foods, Galy and Modern Synthesis who are creating lab-grown coffee, cotton and leather
Founder and CEO,
Compound Foods
Founder and CEO,
Galy
Co-founder and CTO,
Modern Synthesis
Venture Partner,
Petri
Fireside chat:
Mark Smith
Mark Smith is the CEO and co-founder of Finch Therapeutics. Finch is a clinical-stage microbiome therapeutics company.
Co-founder and CEO,
Finch Therapeutics
next generation 'omics
Panel discussion on new ways of measuring nucleic acids, proteins, sugars, lipids, and other biomolecules, across space and time with the founders of Ochre Bio, Biobot Analytics and Matterworks
Co-founder & CEO,
Ochre Bio
Co-founder & CEO
Biobot Analytics
Founder & CEO
Matterworks
